Rocket Lab Corporation $RKLB Stake Reduced by Pandora Wealth Inc.

Key Points

• Pandora Wealth Inc. has reduced its stake in Rocket Lab Corporation by 38.0%, now holding 7,500 shares valued at approximately $268,000.
• Tremendous insider activity occurred with Frank Klein and Matthew Ocko selling significant shares, leading to a 3.33% and 77.57% decrease in their ownership respectively.
• Analysts' ratings include a consensus of Moderate Buy for Rocket Lab, with price targets adjusted upwards by firms like Bank of America and Cantor Fitzgerald to $50.00 and $54.00.

Pandora Wealth Inc. reduced its stake in shares of Rocket Lab Corporation (NASDAQ:RKLB - Free Report) by 38.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,500 shares of the rocket manufacturer's stock after selling 4,600 shares during the quarter. Pandora Wealth Inc.'s holdings in Rocket Lab were worth $268,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. MGO One Seven LLC bought a new position in Rocket Lab during the 2nd quarter worth $584,000. Allspring Global Investments Holdings LLC bought a new position in Rocket Lab during the 2nd quarter worth $285,000. CWM LLC grew its stake in Rocket Lab by 7.0% during the 2nd quarter. CWM LLC now owns 8,491 shares of the rocket manufacturer's stock worth $304,000 after buying an additional 556 shares during the last quarter. Vanguard Personalized Indexing Management LLC grew its stake in Rocket Lab by 69.5% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 23,940 shares of the rocket manufacturer's stock worth $856,000 after buying an additional 9,817 shares during the last quarter. Finally, Hobbs Group Advisors LLC bought a new position in Rocket Lab during the 2nd quarter worth $358,000. 71.78% of the stock is currently owned by institutional investors.

Insider Activity at Rocket Lab

In other news, insider Frank Klein sold 45,535 shares of the company's stock in a transaction on Tuesday, September 16th. The stock was sold at an average price of $48.97, for a total transaction of $2,229,848.95. Following the completion of the sale, the insider directly owned 1,320,291 shares of the company's stock, valued at $64,654,650.27. This represents a 3.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Matthew Ocko sold 1,873,097 shares of the company's stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $48.20, for a total value of $90,283,275.40. Following the sale, the director directly owned 541,526 shares of the company's stock, valued at approximately $26,101,553.20. This represents a 77.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 5,406,361 shares of company stock worth $267,483,973. Company insiders own 11.90% of the company's stock.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Needham & Company LLC reiterated a "buy" rating and set a $55.00 price target on shares of Rocket Lab in a research report on Wednesday, September 3rd. Bank of America boosted their price target on Rocket Lab from $30.00 to $50.00 and gave the stock a "buy" rating in a research report on Wednesday, July 16th. Cantor Fitzgerald boosted their price target on Rocket Lab from $35.00 to $54.00 and gave the stock an "overweight" rating in a research report on Friday, August 8th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Rocket Lab in a research report on Wednesday, October 8th. Finally, KeyCorp boosted their price target on Rocket Lab from $40.00 to $50.00 and gave the stock an "overweight" rating in a research report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $42.27.

Rocket Lab Stock Performance

NASDAQ:RKLB opened at $64.26 on Monday. Rocket Lab Corporation has a twelve month low of $9.20 and a twelve month high of $73.50. The company has a current ratio of 2.67, a quick ratio of 2.33 and a debt-to-equity ratio of 0.60. The company has a 50-day moving average of $48.41 and a 200-day moving average of $35.84. The firm has a market cap of $31.10 billion, a price-to-earnings ratio of -142.80 and a beta of 2.14.

Rocket Lab (NASDAQ:RKLB - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The rocket manufacturer reported ($0.13) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.06). Rocket Lab had a negative net margin of 45.87% and a negative return on equity of 48.14%. The business had revenue of $144.50 million for the quarter, compared to the consensus estimate of $135.42 million. During the same quarter last year, the business posted ($0.08) EPS. The business's revenue for the quarter was up 35.9% on a year-over-year basis. Rocket Lab has set its Q3 2025 guidance at EPS. Analysts forecast that Rocket Lab Corporation will post -0.38 earnings per share for the current fiscal year.

Rocket Lab Company Profile

Rocket Lab USA, Inc, a space company, provides launch services and space systems solutions for the space and defense industries. The company provides launch services, spacecraft design services, spacecraft components, spacecraft manufacturing, and other spacecraft and on-orbit management solutions; and constellation management services, as well as designs and manufactures small and medium-class rockets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.